Stop the Spread condemns the injustice of racism and stands with the black community. Read more on our Twitter account.

Accelerating development and deployment of novel therapies

We believe the most impactful therapeutics will lessen the duration and severity of the disease during the early infection phase. We are working to speed the development and deployment of these early interventions that are both readily scalable and affordable. For this reason, we actively support the use of repurposed drugs with existing safety profiles that will likely move through trials more rapidly.

Accelerating

Deployment and development of novel therapies

We believe the most impactful therapeutics will lessen the duration and severity of the disease during the early infection phase. We are working to speed the development and deployment of these early interventions that are both readily scalable and affordable. For this reason,we actively support the use of repurposed drugs with existing safety profiles that will likely move through trials more rapidly.

Therapeutics: a critical need

Therapeutics will be essential to reduce the burden of COVID-19 while we scale our vaccine infrastructure and beyond. These therapeutics will need to serve communities in both the US and internationally. As such, we are prioritizing low-cost and highly scalable generics with existing safety profiles. We are working with private companies and research centers to advance and support new developments.

&

General Motors & Ventec’s Moonshot: 10,000 ventilators a month

Early in the crisis, General Motors and Ventec Life Systems came together to produce critical care ventilators. Given the urgency of the moment, Ventec needed a manufacturing partner who could rapidly scale production of their leading ventilator technology. Enter GM, who quickly repurposed their Kokomo, Indiana factory to partner with Ventec, and will soon ramping up production to 10,000 ventilators per month.

&

Honda & Dynaflo Pumps: Filling The Gap For Critical Ventilator Components

Dynaflo, Inc. produces a sophisticated compressor that is an essential component in critical care medical ventilators.  Due to the pandemic, Dynaflo was asked to scale up production from roughly 300 per month to 10,000 per month.  Dynaflo was able to work with their supply chain to rapidly increase the supply of needed parts, but faced challenges in assembling compressors at scale. Stop the Spread paired them with Honda of America, given expertise in mass production and willingness to help. The partners are now on track to meet their 10,000 compressors a month goal by June. Together, Honda and DynafloPumps are ensuring that ventilators get off the assembly line and into hospitals on time.

I Can Help:

Resources for Therapeutics

Therapeutics Factbase

Overview of information related to Therapeutics (September 2020)

External Resources